NEW YORK--(BUSINESS WIRE)-- Neurogene Inc. (NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today ...

Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) announced in Q4 CY2024, with sales up 10.3% year on year to $713.4 million. The company expects the full year’s revenue to be around $3.06 ...

Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) will be announcing earnings results this Monday after market ...

Tevogen Bio, a clinical-stage biotech company specializing in immunotherapy, recently met with the BARDA TechWatch team to discuss its ExacTcell technology, which aims to deliver affordable, scalable ...